The Cancer Genome Characterization Initiative (CGCI)
CGCI supports research to comprehensively catalog the genomic alterations in rare adult and pediatric cancers. The research community can use CGCI data to gain insights into the underlying mechanisms of these cancers and identify potential therapeutic targets. The HIV+ Tumor Molecular Characterization Project (HTMCP) and Burkitt Lymphoma Genome Sequencing Project (BLGSP) are two active CGCI projects.
Cancer Genome Characterization Initiative (CGCI) manuscripts from medulloblastoma, diffuse large B-cell lymphoma, non-Hodgkin lymphoma, pediatric Burkitt lymphoma, and HIV-associated cervical cancer projects.
The Cancer Genome Characterization Initiative (CGCI) uses methods such as whole genome, transcriptome, targeted, ChIP sequencing, and methylation arrays.